1. Sponsor Information
The sponsoring organization is the entity with primary responsibility for initiating and conducting the trial(s) to be registered. For trials associated with Investigational New Drug (IND) or Investigational Device Exemption (IDE) applications with the U.S. FDA, the IND/IDE holder is the sponsor.
Type of Organization (select one)
Country of the sponsoring organization.
Official name of sponsoring organization.
Mailing address for the headquarters of the sponsoring organization, including street address, city, state or province, postal code, and country.
Organization Abbreviations and Acronyms
Other names used by the sponsoring organization.
Parent Organizations (if applicable)
Name(s) of larger organization(s) with which the sponsoring organization is affiliated and relationship(s), such as subdivision, division, or department.
Name of official contact person at sponsoring organization. This person may be contacted by ClinicalTrials.gov to verify information about the sponsoring organization and must have the authority to represent the sponsoring organization.
Official Representative Phone
Primary phone number for the official representative, including country code, area code, and extension.
Official Representative Email
Primary email address for the official representative.
Official Web address of the sponsoring organization.
Official name of the primary funding source for the trials to be registered, if different from organization name. In cases involving multiple funding sources, enter the one that provides the greatest amount of funding.
Official name of organizational affiliation of the Investigator, if different from the sponsoring organization.
Primary phone number of the Investigator, including country code, area code, and extension.
Email address for contacting the investigator.
Regulatory Authority Address
Mailing address of the regulatory authority, including street address, city, state or province, postal code, and country.